ETM Experimental and Therapeutic Medicine 1792-0981 1792-1015 D.A. Spandidos 10.3892/etm.2018.5810 ETM-0-0-5810 Articles The investigation of immunomodulatory activities of Gloeostereum incaratum polysaccharides in cyclophosphamide-induced immunosuppression mice WangDi 1 2 * LiQian 2 3 4 * QuYidi 2 * WangMengya 2 3 4 LiLanzhou 2 LiuYang 1 LiYu 1 Engineering Research Center of Chinese Ministry of Education for Edible and Medicinal Fungi, Jilin Agricultural University, Changchun, Jilin 130118, P.R. China School of Life Sciences, Jilin University, Changchun, Jilin 130012, P.R. China Department of Chemistry and Pharmacy, Zhuhai College of Jilin University, Zhuhai, Guangdong 519041, P.R. China Southern Research Institute, Jilin University, Zhuhai, Guangdong 519041, P.R. China Correspondence to: Professor Yu Li, Engineering Research Center of Chinese Ministry of Education for Edible and Medicinal Fungi, Jilin Agricultural University, 2888 Xincheng Street, Changchun, Jilin 130118, P.R. China, E-mail: fungi966@163.com

Contributed equally

 04 2018 30 01 2018 15 4 3633 3638 12092017 22012018 Copyright © 2018, Spandidos Publications 2018

Gloeostereum incarnatum, a precious edible mushroom, displays anti-bacterial and anti-inflammatory activities; however, its immunomodulatory effect has not been studied yet. The present study aimed to investigate whether polysaccharide compositions of G. incarnatum polysaccharides (GIPS) possess immunomodulatory and immuno-enhancing effects in a Cyclophosphamide monohydrate (CTX)-induced BALB/c mice model. The 28-day GIPS administration at doses of 0.1, 0.3 and 0.9 g/kg remarkably reversed the bodyweight loss, increased the thymic index and promoted T lymphocyte proliferation in CTX-induced immunosuppressed mice. GIPS significantly raised the serum levels of immunoglobulin (Ig)A and IgG, promoted the production of interleukins (ILs), including IL-2, IL-3 and IL-6, interferons, including interferon (IFN)-α and IFN-γ, and monocyte chemotactic protein 1 in the spleen, which resulted in accelerating recovery of immunosuppression. Finally, GIPS showed anti-oxidative effects indicated by the increased superoxide dismutase levels in the serum and spleen, and the reduced level of reactive oxygen species in the spleen. The results of the current study demonstrated that GIPS positively adjusts the immune system, which may serve as a potential immunostimulatory agent.

 Gloeostereum incaratum immunomodulatory effect polysaccharides cyclophosphamide oxidative stress Introduction

The immune system, a complex self-regulation system, is responsible for the defense function of organism to prevent outside pathogens, remove the waste material and maintain the monitoring function for malignant cells (1). The immune system is highly sensitive (2), and shows impaired immune responsiveness to pathogen invasion, during which, immune cells are activated and secret pro-inflammatory mediators including interleukins (ILs) and interferons (INFs) are increased (3,4). And immunity closely related to oxidative stress, which could lead to aberrant expression of inflammatory cytokines and chemokines (5). Cyclophosphamide monohydrate (CTX), a cancer chemotherapeutic agent, facilitates cell apoptosis and decreases the homeostatic proliferation of regulatory T cells (6), which has been widely used in the establishment of immunosuppressive animal models (7–9).

Previous researchers focus their studies on searching immunomodulatory agents for years (10). However, the drugs performed in clinic, especially single-component chemicals, display severe adverse effects including general malaise and/or neurotoxicity (11,12), which is hard to meet the requirements of immunosuppressive patients. Dietary polysaccharides from natural products are getting more attention due to their health benefits and low toxicity (13,14), which have been confirmed to exhibit multiple immunomodulatory effects (15,16). Gloeostereum incarnatum, a precious edible mushroom, parasitizes broad-leaved wood in northern Japan and northern China (17). Traditionally, G. incarnatum preparation is widely used for the treatment for enteritis, dysentery and gastric ulcer (18). Polysaccharides obtained from G. incarnatum fruiting body have been reported to possess anti-tumor and anti-bacterial activities (17). However, the immunomodulatory effect of G. incarnatum has not been investigated yet.

The objective of this study aims to investigate whether polysaccharide compositions of G. incarnatum possess immunomodulatory and immuno-enhancing effects in a CTX-induced BALB/c mice model. Data demonstrated that G. incarnatum polysaccharides (GIPS) enhanced immunologic function in CTX-induced immunosuppressed mice by promoting the production of immune-associated factors in spleen, elevating serum immunoglobulin (Ig) levels, and restoring the imbalance of anti-oxidation and oxidation.

 Materials and methods <sec> <title>GIPS preparation

G. incaratum fruiting body (Yunnan, China) was smashed and extracted with 20-fold double distilled (D.D.) water at 90°C for 4 h twice. The water extracts were concentrated and deproteinated by Sevag agents (n-butanol:chloroform=1:4) (19). After centrifugation, the supernatant were collected, added 4-fold volume of ethanol, and placed at 4°C for overnight. The precipitation was dissolved in D.D. water and subjected to DEAE-52 cellulose anion exchange column (2.6×35 cm) (20). The fractions (fraction 1 to 4) of crude GIPS were collected together, freeze dried and stored at −80°C. The detailed information can be found in Fig. 1A and B.

 Protocols for immunosuppression mice development and agents administration

The experimental protocol was approved by Animal Ethics Committee in Jilin University (20160402). 72 of Balb/c male mice (8-week old, 18–20 g) [SCXK (JI)-2014-0003] were housed in cages with a 12 h light/12 h dark period under a constant temperature (23±2°C) and humidity-controlled conditions (50–60%), and allowed free access to solid feed and tap water during the experiments.

After one-week acclimatization, mice were divided into six groups randomly as follows. Control group (n=12): 3-day normal saline injection following with 14-day normal saline gastric gavages. Cyclophosphamide (CTX)-injected group (model group; n=12): 3-day CTX (75 mg/kg; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) injection following with 14-day normal saline gastric gavages. GIPS-treated groups (n=12/group): 3-day CTX (75 mg/kg) injection following with 14-day GIPS (0.1, 0.3 and 0.9 g/kg; dissolved in normal saline) gastric gavages. Thymosin α1 (Tα1) (positive drug)-treated group (n=12): 3-day CTX (75 mg/kg) injection following with 14-day Tα1 (0.16 mg/kg; Jiangsu Hengrui Medicine Co., Ltd., Lianyungang, China) injection. General health and body weights of mice were monitored during the whole experimental period. At 24 h after the last administration, all mice were weighted, and killed. Blood and organs (spleen and thymus) were sampled immediately. The thymus index was calculated according to the formula: Index (mg/10 g)=(Weight of thymus)/10 × (body weight).

 Lymphocyte proliferation assay

Spleen of each mouse was aseptically removed and grounded into a single cell suspension (21), and seeded into a 96-well plate at density of 1×106/100 µl mixed with 10 µl of RPMI-1640 (Control group) or 10 µl of 200 µg/ml concanavalin (ConA; Sigma-Aldrich; Merck KGaA). Then incubated under a humidified atmosphere containing 5%/95% CO2/air at 37°C for 48 h similar as previous study (22), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma-Aldrich; Merck KGaA) assay were performed to analysis the changes of cell viability. The stimulation index (SI) of T lymphocyte transformation was calculated as following equation: SI=OD490 ConA/OD490 control.

 ELISA assay

The spleens were homogenized with D.D. water, and the protein concentrations were detected by a bicinchoninic acid protein assay kit (Merck KGaA). The levels of superoxide dismutase (SOD; 43125), ROS (43355), IgA (42791), IgG (42793) and IgM (42794) in serum and spleen, and the levels of ILs [IL-2 (42903), −3 (42902) and −6 (42912)], INFs [IFN-α (43102) and IFN-γ (42918)] and monocyte chemotactic protein 1 (MCP-1; 42818) in spleen were detected by commercial ELISA kits (Shanghai Yuanye Bio-Technology Co., Ltd., Shanghai, China).

 Statistical analysis

The statistical values are presented as the mean ± standard error of the mean (SEM). Statistically comparisons were analyzed using a one-way analysis of variance (ANOVA) followed by Dunn's test via SPSS 16.0 software (IBM Corp., Armonk, NY, USA). P<0.05 was considered to indicate a statistically significant difference.

 Results <sec> <title>Effects of GIPS on bodyweight, thymus index and lymphocyte proliferation

CTX strongly reduced the bodyweights of mice after 3-day injection (P<0.05; Table I); in contrast, GIPS and Tα1 improved the weight gain in immunosuppressed mice after 7-day administration (P<0.05; Table I). Compared to normal mice, extremely low thymus index was observed in CTX-injected mice (P<0.001; Table I). GIPS at doses of 0.1, 0.3 and 0.9 g/kg and Tα1 at 0.16 mg/kg significantly enhanced the thymus index after 14-day treatment (P<0.05; Table I).

Lymphocyte proliferation is commonly used to reflect the immune function (23). Compared to CTX-induced immunosuppressant mice, GIPS at 0.9 g/kg, but not Tα1 promoted over 21.3% T lymphocyte proliferation (P<0.05; Fig. 2).

 GIPS enhanced immune globulin levels in the serum and spleen of immunosuppressed mice

CTX injection suppressed the levels of IgA and IgG in serum (P<0.01; Fig. 3A and B), and reduced the levels of IgG and IgM in spleen (P<0.01; Fig. 3B and C) of mice. Compared to CTX-induced immunosuppressant mice, Tα1 at 0.16 mg/kg significantly enhanced the levels of IgA, IgG and IgM in serum (P<0.01; Fig 3), and the levels of IgG in spleen (P<0.01; Fig. 2B). Differently, GIPS failed to increase the spleen levels of immune globulin in CTX-induced immunosuppressant mice (Fig. 3). In contrast, GIPS administration resulted in >13.0% enhancement on IgA levels except for 0.1 g/kg of GIPS (P<0.001; Fig 3A) and >16.8% enhancement on IgG levels (P<0.05; Fig 3B) in serum of CTX-induced immunosuppressant mice.

 Effects of GIPS on immune factors in the spleen of immunosuppressed mice

Compared to normal mice, the levels of ILs (IL-2, −3 and −10), INFs (IFN-α and IFN-γ) and MCP-1 in spleen were significantly lowered in CTX-induced immunosuppressant mice (P<0.05; Table II), which were all significantly restored by 14-day Tα1 administration at 0.16 mg/kg (P<0.05; Table II). GIPS, especially at 0.9 g/kg, increase 191.1% of IL-2 (P<0.01), 94.7% of IL-3 (P<0.01), 136.1% of IL-6 (P<0.001), 68.7% of IFN-α (P<0.05), 50.6% of IFN-γ (P<0.05), and 77.8% of MCP-1 (P<0.001) in spleen compared to CTX-injected mice (Table II).

 Effects of GIPS on the oxidative stress factors in serum and spleen of immunosuppressed mice

Compared to normal mice, CTX injection strongly reduced the levels of SOD in serum and spleen (P<0.001; Table III), but failed to significantly influence ROS levels (Table III). Tα1 only enhanced the levels of SOD (P<0.01; Table III), but not ROS, in serum and spleen of CTX-injected mice. Compared to immunosuppressed mice, 14-day GIPS administration resulted in >14.6% and >51.5% enhancement on SOD levels in serum (except for 0.1 g/kg GIPS) and spleen, respectively (P<0.05; Table III). GIPS showed no effects on serum ROS levels (Table III); in contrast, GIPS at doses of 0.3 and 0.9 g/kg significantly reduced the levels of ROS in spleen compared to immunosuppressed mice (P<0.01; Table III).

 Discussion

In this study, we evaluated the immunoregulation effect of GIPS in CTX-induced immunosuppressed mice, and this model is recognized as a well characterized model. There are reports that, CTX shows immunosuppressive effect mainly through lymphocytes toxicity via disturbing DNA and RNA function (24,25). GIPS significantly reversed the atrophy of immune organs, especially thymus, and enhanced T lymphocyte proliferation. Spleen, an important immune organ, is the primary site for the development of T cells and B cells (26). The proliferation of T and B lymphocytes in response to microbial antigen is known as a typical non-specific immune reaction. Thus, the determination of lymphocyte proliferation can reflect the immune status (23). Moreover, GIPS increased the serum Ig levels in CTX-induced immunosuppressed mice. Ig is the crucial component of organism immune system and plays a vital role in immune function (27). IgG is found to be the most abundant Igs and mediates natural passive immunity including antibacterial, antivirus and antitoxin (28); meanwhile, IgA shows bacteriolysis and promotive function in phagocytosis and aggregation (29). Immuno-stimulants, such as bacterial antigen lysate, significantly enhanced IgG and IgA serum levels in children with recurrent infections (30,31). IgM, one of the largest molecular weight Ig, accounts or 5–10% of the total serum Ig, which appears firstly in the humoral immune response of antibodies (32). The detection of serum IgM levels serves as an index of the early diagnosis of infection. Altogether, we successfully confirmed the immunoregulation activities of GIPS in the CTX-induced immunosuppressed mouse model.

GIPS successfully regulated the levels of ILs, INFs and MCP-1 in spleen of CTX-induced immunosuppressed mice. The immune response targets various cytokines, some of which directly influence immunity of organs. T helper (Th) cells, one of subsets of T cells, mediates the production of ILs, which can active immune cells during immune response evidencing by huper-levels of IL-2 activates pro-inflammatory CD4+ T cells (33). IL-3 participates in regulating myeloid cell expansion, autoimmunity and modulate human CD14+ monocyte response in short-term or long-term models of trained immunity (34). IL-6 is a critical factor for maturation, proliferation, differentiation and maintenance of B cells/plasma cells, which seems to enhance the development of pro-inflammatory cell and to inhibit the development T regulatory cells (35). IL-6 promotes the expression of IL-2 in T cells, which further interacts with IL-3 to promote the differentiation of T cells (36). Moreover, Th1 cells secretes IFN-α and IFN-γ, which promotes cytotoxic lymphocytes formation and activity of macrophage (37,38). IFN-γ, an essential cytokine for host defense against pathogens, can stimulate macrophages to eliminate bacterial and tumor cell, activate neutrophil and natural killer (NK) cell (37). GIPS significantly enhanced the levels of MCP-1 in spleen of CTX-induced immunosuppressed mice. MCP-1, a member of the CC chemokine family, is responsible for recruiting monocytes, T cells and dendritic cells to inflammatory sites caused by infection (39). All the data obtained in our present experiment further confirmed the immunoregulation activities of GIPS in CTX-induced immunosuppressed mice.

On the other hand, ooxidative stress is identified as one of the pathogenic factor of the immune system in inflammatory diseases (40), which has an effect on human T cell differentiation and polarization (41). The immune cell functions are mainly associated with the imbalance of the antioxidant/oxidant, especially the over-generation of ROS (42). Therefore, it is beneficial to prevent the injury of immune cells and maintain normal immune system function with adequate amounts of antioxidants (43). The balance between production and consumption of ROS is a key factor that determines the the physiological activities and function of T cells (44). SOD, the endogenous anti-oxidant, is the recognized as the first line of defense of oxidative stress, especially helping to scavenging ROS (45). GIPSsignificantly enhanced the levels of SOD in serum and spleen, and reduced the levels of ROS in spleen of CTX-induced immunosuppressed mice. However, more experiments need to be performed to investigate the roles of anti-oxidation of GIPS during its immunoregulation effects.

To our knowledge, we first confirmed the immunomodulatory effects of G. incaratum in the CTX-induced immunosuppressed mouse model, and provided the experimental evidence for the use of GIPS as a potential immunostimulatory agent. Although we found that GIPS can regulate the levels of ILs, INFs and oxidative stress factors, the underlying mechanism still need further investigation.

 Acknowledgements

This study was supported by Science and Technology Key Project in Jilin Province of China (nos. 20160520036JH and 20160204029YY), China Postdoctoral Science Foundation (no. 2016M591495) and the Special Projects of Cooperation between Jilin University and Jilin Province (grant no. SXGJSF2017-1).

 References LohLWangZFSantSKoutsakosMJegaskandaSCorbettAJLiuLFairlieDPCroweJRossjohnJHuman mucosal-associated invariant T cells contribute to antiviral influenza immunity via IL-18-dependent activationProc Natl Acad Sci USA1131013310138201610.1073/pnas.161075011327543331 CollopyKTKivlehanSMSnyderSRThe impaired immune systemHow is it suppressed and what does it mean for EMS? EMS World421151182013 YoshimuraASuzukiMSakaguchiRHanadaTYasukawaHSOCS, inflammation and autoimmunityFront Immunol320201210.3389/fimmu.2012.0002022566904 FerlazzoGTsangMLMorettaLMelioliGSteinmanRMMünzCHuman dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cellsJ Exp Med195343351200210.1084/jem.2001114911828009 ReuterSGuptaSCChaturvediMMAggarwalBBOxidative stress, inflammation, and cancer: How are they linked?Free Radic Biol Med4916031616201010.1016/j.freeradbiomed.2010.09.00620840865 GoldsteinMRoosWPKainaBApoptotic death induced by the cyclophosphamide analogue mafosfamide in human lymphoblastoid cells: Contribution of DNA replication, transcription inhibition and Chk/p53 signalingToxicol Appl Pharmacol2292032200810.1016/j.taap.2008.01.00118289623 FreyBMMechanism of action of immunosuppressive agentsTher Umsch5071761993(In German)8456418 GassmannWUharekLWottgeHUSchmitzNLöfflerHMueller-RuchholtzWComparison of cyclophosphamide, cytarabine, and etoposide as immunosuppressive agents before allogeneic bone marrow transplantationBlood721574157919883052627 FanYMaLZhangWXuYSuolangzhaxiZhiXCuiESongXMicroemulsion can improve the immune-enhancing activity of propolis flavonoid on immunosuppression and immune responseInt J Biol Macromol63126132201410.1016/j.ijbiomac.2013.09.03924099936 GaoHYLiGYHuangJHanYSunFZDuXWAnLJWangHYWangJHProtective effects of Zhuyeqing liquor on the immune function of normal and immunosuppressed mice in vivoBMC Complement Altern Med13252201310.1186/1472-6882-13-25224090456 PłonkaPMHair pigmentation disorders or 50 years of German-Polish alliance for study on a severe side effect of chemotherapy: Kostanecki's legacyExp Dermatol241011201510.1111/exd.1256025279945 MarkmanMChemotherapy-associated neurotoxicity: An important side effect-impacting on quality, rather than quantity, of lifeJ Cancer Res Clin Oncol122511512199610.1007/BF012135478781565 RenLPereraCHemarYAntitumor activity of mushroom polysaccharides: A reviewFood Funct311181130201210.1039/c2fo10279j22865023 Ben JeddouKChaariFMaktoufSNouri-EllouzOHelbertCBGhorbelREStructural, functional, and antioxidant properties of water-soluble polysaccharides from potatoes peelsFood Chem20597105201610.1016/j.foodchem.2016.02.10827006219 ZhouLLiuZWangZYuSLongTZhouXBaoYAstragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivoSci Rep744822201710.1038/srep4482228303957 ZhengYWangQZhuangWLuXMironAChaiTTZhengBXiaoJCytotoxic, antitumor and immunomodulatory effects of the water-soluble polysaccharides from lotus (Nelumbo nucifera Gaertn.) seedsMolecules21pii: E1465201610.3390/molecules21111465 AsaiRMitsuhashiSShigetomiKMiyamotoTUbukataMAbsolute configurations of (−)-hirsutanol A and (−)-hirsutanol C produced by Gloeostereum incarnatumJ Antibiot (Tokyo)64693696201110.1038/ja.2011.7321878943 BunbamrungNIntaraudomCDramaeABoonyuenNVeeranondhaSRachtaweePPittayakhajonwutPAntimicrobial activity of illudalane and alliacane sesquiterpenes from the mushroom Gloeostereum incarnatum BCC41461Phytochem Lett20274281201710.1016/j.phytol.2017.05.017 YanHZhuDXuDWuJBianXA study on Cordyceps militaris polysaccharide purification, composition and activity analysisAfr J Biotechnol7400440092008 ZhangALLuJhZhangNZhengDZhangGRTengLRExtraction, purification and anti-tumor activity of polysaccharide from mycelium of mutant cordyceps militarisChem Res Chin Univ267988022010 JiaDLuWWangCSunSCaiGLiYWangGLiuYZhangMWangDInvestigation on immunomodulatory activity of calf spleen extractive injection in cyclophosphamide-induced immunosuppressed mice and underlying mechanismsScand J Immunol842027201610.1111/sji.1244227104480 RoehmNWRodgersGHHatfieldSMGlasebrookALAn improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTTJ Immunol Methods142257265199110.1016/0022-1759(91)90114-U1919029 ChoCWHanCJRheeYKLeeYCShinKSShinJSLeeKTHongHDCheonggukjang polysaccharides enhance immune activities and prevent cyclophosphamide-induced immunosuppressionInt J Biol Macromol72519525201510.1016/j.ijbiomac.2014.09.01025236609 MisraRRBloomSERoles of dosage, pharmacokinetics, and cellular sensitivity to damage in the selective toxicity of cyclophosphamide towards B and T cells in developmentToxicology66239256199110.1016/0300-483X(91)90196-82011850 FraiserLHKanekalSKehrerJPCyclophosphamide toxicity. Characterising and avoiding the problemDrugs42781795199110.2165/00003495-199142050-000051723374 KuwanaMOkazakiYKaburakiJKawakamiYIkedaYSpleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpuraJ Immunol16836753682200210.4049/jimmunol.168.7.367511907134 ClemLWSmallPAJrPhylogeny of immunoglobulin structure and function. V. Valences and association constants of teleost antibodies to a haptenic determinantJ Exp Med132385400197010.1084/jem.132.3.3854109109 QuastIPeschkeBLünemannJDRegulation of antibody effector functions through IgG Fc N-glycosylationCell Mol Life Sci74837847201710.1007/s00018-016-2366-z27639381 HerichRIs the role of IgA in local immunity completely known?Food Agric Immunol281152016 SanadMMAl-FuraeihiLMEffect of some immunomodulators on the host-parasite system in experimental Hymenolepiasis nanaJ Egypt Soc Parasitol366580200616605101 QuezadaAMaggiLPèrezMARodríguezJEffect of bacterial antigen lysate on IgG and IgA levels in children with recurrent infections and hypogammaglobulinemiaJ Investig Allergol Clin Immunol9178182199910412680 MaverakisEKimKShimodaMGershwinMEPatelFWilkenRRaychaudhuriSRuhaakLRLebrillaCBGlycans in the immune system and the altered glycan theory of autoimmunity: A critical reviewJ Autoimmun57113201510.1016/j.jaut.2014.12.00225578468 ZhuJYamaneHPaulWEDifferentiation of effector CD4 T cell populations (')Annu Rev Immunol28445489201010.1146/annurev-immunol-030409-10121220192806 BorrielloFIannoneRDi SommaSLoffredoSScamardellaEGaldieroMRVarricchiGGranataFPortellaGMaroneGGM-CSF and IL-3 modulate human monocyte TNF-α production and renewal inin vitromodels of trained immunityFront Immunol7680201628138327 TvedtTHAErsvaerETveitaAABruserudØInterleukin-6 in allogeneic stem cell transplantation: Its possible importance for immunoregulation and as a therapeutic targetFront Immunol8667201710.3389/fimmu.2017.0066728642760 DienzORinconMThe effects of IL-6 on CD4 T cell responsesClin Immunol1302733200910.1016/j.clim.2008.08.01818845487 CopeALe FriecGCardoneJKemperCThe Th1 life cycle: Molecular control of IFN-γ to IL-10 switchingTrends Immunol32278286201110.1016/j.it.2011.03.01021531623 MaJJYangBYYuSFZhangYZhangXLaoSChenXLiBWuCTuberculosis antigen-induced expression of IFN-α in tuberculosis patients inhibits production of IL-1βFaseb J2832383248201410.1096/fj.13-24705624675363 XuLLWarrenMKRoseWLGongWWangJMHuman recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitroJ Leukoc Biol60365371199610.1002/jlb.60.3.3658830793 EgeaJFabregatIFrapartYMGhezziPGörlachAKietzmannTKubaichukKKnausUGLopezMGOlaso-GonzalezGEuropean contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)Redox Biol1394162201710.1016/j.redox.2017.05.00728577489 KingMRIsmailASDavisLSKarpDROxidative stress promotes, polarization of human T cell differentiation toward a T helper 2 phenotypeJ Immunol17627652772200610.4049/jimmunol.176.5.276516493032 De la FuenteMEffects of antioxidants on immune system ageingEur J Clin Nutr56Suppl 3S5S8200210.1038/sj.ejcn.160147612142953 GutteridgeJMMitchellJRedox imbalance in the critically illBr Med Bull554975199910.1258/000714299190229510695079 ChenXSongMZhangBZhangYReactive oxygen species regulate T cell immune response in the tumor microenvironmentOxid Med Cell Longev20161580967201610.1155/2016/158096727547291 IslamMTOxidative stress and mitochondrial dysfunction-linked neurodegenerative disordersNeurol Res397382201710.1080/01616412.2016.125171127809706

(A) The Scheme for extraction and isolation of polysaccharides from G. incarnatum. (B) DEAE-Sepharose fast flow chromatogram of the crude polysaccharides.

GIPS enhanced the lymphocyte proliferation of spleen in CTX-induced immunosuppressed mice. Data were expressed as means ± SEM (n=12). ###P<0.001 vs. control group, *P<0.05 vs. model group. CTX, Cyclophosphamide; GIPS, G. incarnatum polysaccharides; Tα1, Thymosin α1.

The regulatory effects of GIPS (0.1, 0.3 and 0.9 g/kg) and Tα1 (0.16 mg/kg) on the levels of (A) IgA, (B) IgG and (C) IgM in serum and spleen of CTX-induced immunosuppressed mice. Data were expressed as means ± SEM (n=12). ##P<0.01 and ###P<0.001 vs. control group, *P<0.05 and **P<0.01 vs. model group. CTX, Cyclophosphamide; GIPS, G. incarnatum polysaccharides; Tα1, Thymosin α1.

Regulatory effects of GIPS and Tα1 on body weight and organ indexes.

CTX (mg/kg) GIPS (g/kg) Tα1 (mg/kg)
Measurement CTRL 75 0.1 0.3 0.9 0.16
Body weight (g)
  1st day 26.4±0.4 25.8±0.4 27.1±0.3 25.0±0.4 27.4±0.6 26.9±0.4
  4th day 25.8±0.3 22.6±0.5a 22.4±0.4 22.8±0.7 22.8±0.6 22.5±0.4
  11th day 27.9±0.4 24.6±0.3a 25.6±0.5 25.3±0.8 26.9±0.5c 24.8±0.6
  18th day 27.3± 0.6 23.1±0.4a 25.1±0.2 24.7±0.9 26.0±0.8c 25.9±1.1c
Thymus index (mg/10 g) 0.23±0.02 0.09±0.01b 0.14±0.02d 0.13±0.03c 0.17±0.03d 0.15±0.03d

The changes of body weight were detected during the experimental period. After 14-day administration, thymus index was examined. Data were expressed as means ± SEM (n=12).

P<0.05

P<0.001 vs. control group

P<0.05

P<0.01 vs. model group. CTX, Cyclophosphamide; GIPS, G. incarnatum polysaccharides; Tα1, Thymosin α1; CTRL, control.

Regulatory effects of GIPS and Tα1 on interleukins, interferons and MCP-1 in spleen of CTX-induced immunosuppressed mice.

GIPS (g/kg) Tα1 (mg/kg)
Protein CTRL Model 0.1 0.3 0.9 0.16
IL-2 (pg/mg) 21.2±1.0 6.7±0.8b 9.0±0.4 9.5±1.0 19.5±4.0d 12.0±0.7c
IL-3 (pg/mg) 6.4±0.37 3.8±0.4a 4.7±0.5 5.2±0.4 7.4±1.3d 6.0±0.7c
IL-6 (pg/mg) 9.7±0.7 3.6±0.5b 5.7±0.4 6.6±0.6c 8.5±1.1e 7.2±0.7d
IFN-α (pg/mg) 2.6±0.2 1.6±0.1a 2.4±0.1 2.6±0.3 2.7±0.1c 3.6±0.5d
IFN-γ (pg/mg) 15.4±0.8 7.9±0.6b 9.5±0.8 9.2±0.5 11.9±1.3c 12.4±1.2d
MCP-1 (pg/mg) 1.3±0.1 0.9±0.1b 1.2±0.1d 1.5±0.1e 1.6±0.1e 1.3±0.1d

Data were expressed as means ± SEM (n=12).

P<0.05

P<0.001 vs. control group

P<0.05

P<0.01

P<0.001 vs. model group. CTX, Cyclophosphamide; GIPS, G. incarnatum polysaccharides; Tα1, Thymosin α1; CTRL, control; IL, interleukin; IFN, interferon; MCP, monocyte chemotactic protein.

Regulatory effects of GIPS and Tα1 on the levels of SOD and ROS in serum and spleen of CTX-induced immunosuppressed mice.

GIPS (g/kg) Tα1 (mg/kg)
Group CTRL Model 0.1 0.3 0.9 0.16
Serum
  SOD (U/ml) 150.5±6.1 113.3±4.0a 119.0±3.1 129.8±1.6b 136.8±3.9c 138.0±3.1c
  ROS (U/ml) 32.6±0.6 33.3±0.6 32.0±1.0 31.75±1.6 31.2±1.4 34.1±1.0
Spleen
  SOD (U/mg) 30.5±2.2 16.5±1.2a 25.0±2.3b 26.1±0.6b 27.8±2.5c 32.4±2.1d
  ROS (U/mg) 39.8±2.7 42.7±7.1 30.7±1.9 28.2±2.9b 23.1±2.4c 30.4±2.9

Data were expressed as means ± SEM (n=12).

P<0.001 vs. control group

P<0.05

P<0.01

P<0.001 vs. model group. CTX, Cyclophosphamide; GIPS, G. incarnatum polysaccharides; Tα1, Thymosin α1; CTRL, control; SOD, superoxide dismutase; ROS, reactive oxygen species.